
Home » Pipeline
Pipeline
Company | Drug/Device | Medical Condition | Status |
---|---|---|---|
Abbott | optical coherence tomography (OTC) | high-risk, complex coronary artery disease | Phase I trials initiated enrolling 3,650 subjects in North America, Europe and Asia |
Translate Bio | MRT5005 | first-in-human clinical trial in patients with cystic fibrosis | Phase I/II clearance given by the FDA |
Adynxx Inc. | brivoligide (AYX1) | post-surgical pain | Phase II results announced |
GTx, Inc. | enobosarm | post-menopausal stress urinary incontinence (SUI) | Phase II trials initiated enrolling 493 subjects at over 60 clinical trial centers across the U.S. |
BiondVax Pharmaceuticals Ltd. | M-001 | universal flu vaccine | Phase II trials initiated enrolling 9,630 subjects age 50 years and older across four-to-six countries over a period of two flu seasons |
Therapix Ltd. | THX-110 | adult subjects with Tourette syndrome | Phase IIa topline results announced |
AbbVie | upadacitinib | moderate to severe Rheumatoid Arthritis | Phase III topline results announced evaluating 37 subjects |
Stealth Biotherapeutics | elamipretide | Barth syndrome | Orphan Drug Designation granted |
Clovis Oncology Inc. | Rubraca (rucaparib) tablets | adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy | FDA approval granted |
Upcoming Events
-
12Apr
-
25Apr
-
26Apr
-
27Apr
-
17May
-
21May